New hope for COPD patients: experimental pill aims to reduce dangerous lung Flare-Ups
NCT ID NCT07351734
Summary
This study is testing whether a new tablet called JKN2403 can help adults with moderate-to-severe COPD by reducing the frequency of serious symptom flare-ups and improving quality of life. About 120 participants will take either the real drug or a placebo pill daily for 24 weeks while researchers track their breathing, symptoms, and flare-up rates. The main goal is to see if JKN2403 is safe and more effective than a dummy pill at controlling this chronic lung disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD, CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.